PT - JOURNAL ARTICLE AU - Costa, Pedro Fragoso AU - Püllen, Lukas AU - Kesch, Claudia AU - Krafft, Ulrich AU - Tschirdewahn, Stephan AU - Moraitis, Alexandros AU - Radtke, Jan Philipp AU - Ting, Saskia AU - Nader, Michael AU - Wosniack, Jasmin AU - Kersting, David AU - Lückerath, Katharina AU - Herrmann, Ken AU - Fendler, Wolfgang Peter AU - Hadaschik, Boris Alexander AU - Darr, Christopher TI - <sup>18</sup>F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in Men AID - 10.2967/jnumed.122.264670 DP - 2023 Apr 01 TA - Journal of Nuclear Medicine PG - 598--604 VI - 64 IP - 4 4099 - http://jnm.snmjournals.org/content/64/4/598.short 4100 - http://jnm.snmjournals.org/content/64/4/598.full SO - J Nucl Med2023 Apr 01; 64 AB - Intraoperative identification of positive resection margins (PRMs) in high-risk prostate cancer (PC) needs improvement. Cerenkov luminescence imaging (CLI) with 68Ga-PSMA-11 is promising, although limited by low residual activity and artificial signals. Here, we aimed to assess the value of CLI and flexible autoradiography (FAR) with 18F-PSMA-1007. Methods: Mice bearing subcutaneous PSMA-avid RM1-PGLS tumors were administered 18F-PSMA-1007, and PET/CT was performed. After the animals had been killed, organs were excised and measured signals in CLI and FAR CLI were correlated with tracer activity concentrations (ACs) obtained from PET/CT. For clinical assessment, 7 high-risk PC patients underwent radical prostatectomy immediately after preoperative 18F-PSMA PET/CT. Contrast-to-noise ratios (CNRs) were calculated for both imaging modalities in intact specimens and after incision above the index lesion. Results: In the heterotopic in vivo mouse model (n = 5), CLI did not detect any lesion. FAR CLI detected a distinct signal in all mice, with a lowest AC of 7.25 kBq/mL (CNR, 5.48). After incision above the index lesion of the prostate specimen, no increased signal was observed at the cancer area in CLI. In contrast, using FAR CLI, a signal was detectable in 6 of 7 patients. The AC in the missed index lesion was 1.85 kBq/mL, resulting in a detection limit of at least 2.06 kBq/mL. Histopathology demonstrated 2 PRMs, neither of which was predicted by CLI or FAR CLI. Conclusion: 18F-PSMA FAR CLI was superior to CLI in tracer-related signal detectability. PC was could be visualized in radical prostatectomy down to 2.06 kBq/mL. However, the detection of PRMs was limited. Direct anatomic correlation of FAR CLI is challenging because of the scintillator overlay.